GRANULES vs STAR: Stock Comparison
GRANULES INDIA is the larger company by market capitalisation. GRANULES INDIA shows a higher ROE, faster revenue growth and lower leverage, while STRIDES PHARMA SCI shows a lower P/E and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
GRANULES leads 7; STAR leads 4 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | GRANULES | STAR |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
Price
| Metric | GRANULES | STAR |
|---|---|---|
| Live Price | ₹853.15 | ₹994.4 |
| Day Change | 1.89% | -9.39% |
| Volume | 3 L | 4.63 L |
| 52-Week High | ₹923.65 | ₹1,260.9 |
| 52-Week Low | ₹529.85 | ₹768.65 |
| Distance from 52W High | -7.63% | -21.14% |
Valuation
| Metric | GRANULES | STAR |
|---|---|---|
| Market Cap | ₹23,283 Cr | ₹9,431 Cr |
| P/E Ratio | 31.22x | 16.5x |
| P/B Ratio | 4.1x | 3.26x |
| EPS | ₹26.92 | ₹17.02 |
| Book Value | ₹205.21 | ₹341.68 |
| Dividend Yield | 0.21% | 0.46% |
Growth
| Metric | GRANULES | STAR |
|---|---|---|
| Revenue Growth (TTM YoY) | 22.8% | 11.2% |
| EPS Growth (TTM YoY) | 31.3% | 54.4% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | GRANULES | STAR |
|---|---|---|
| ROE | 9.11% | 5.59% |
| ROCE | 9.07% | 4.43% |
| Net Margin | 11.15% | 10.58% |
| Operating Margin | 17.19% | 14.53% |
| Debt to Equity | 0.17x | 0.35x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | GRANULES | STAR |
|---|---|---|
| Promoter Holding | 37.08%▼ 0.59 pp | 29%▲ 1.09 pp |
| FII Holding | 20.25%▲ 2.75 pp | 27.98%▼ 0.41 pp |
| DII Holding | 15.33%▼ 0.78 pp | 15.51%▲ 0.1 pp |
| Public Holding | 27.04%▼ 1.34 pp | 27.51%▼ 0.77 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GRANULES INDIA and STRIDES PHARMA SCI.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.